Tyra Biosciences, Inc.
TYRA
$36.22
$0.220.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -119.95M | -111.68M | -105.83M | -96.44M | -86.48M |
| Total Depreciation and Amortization | 546.00K | 558.00K | 554.00K | 540.00K | 519.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.89M | 23.91M | 22.72M | 19.59M | 16.92M |
| Change in Net Operating Assets | -1.63M | -3.89M | -4.06M | 3.11M | -729.00K |
| Cash from Operations | -95.14M | -91.11M | -86.63M | -73.20M | -69.77M |
| Capital Expenditure | -141.00K | -90.00K | -103.00K | -542.00K | -664.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 72.60M | 45.13M | 81.51M | -83.91M | -97.74M |
| Cash from Investing | 72.46M | 45.04M | 81.41M | -84.45M | -98.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.10M | 4.12M | 4.22M | 4.26M | 202.56M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | -251.00K | -420.00K |
| Cash from Financing | 8.10M | 4.12M | 4.22M | 4.01M | 202.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.58M | -41.94M | -1.00M | -153.65M | 33.96M |